Get the Stockscreener App
14.81
1.86%
-0.28
After Hours:
14.88
0.07
+0.47%
Instil Bio Inc stock is traded at $14.81, with a volume of 50,897.
It is down -1.86% in the last 24 hours and down -22.98% over the past month.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
See More
Previous Close:
$15.09
Open:
$15.8
24h Volume:
50,897
Relative Volume:
0.42
Market Cap:
$99.98M
Revenue:
-
Net Income/Loss:
$-74.14M
P/E Ratio:
-1.3003
EPS:
-11.39
Net Cash Flow:
$-65.70M
1W Performance:
-9.14%
1M Performance:
-22.98%
6M Performance:
+11.94%
1Y Performance:
-51.98%
1-Day Range:
$14.74
$15.80
1-Week Range:
$13.76
$16.34
52-Week Range:
$10.80
$42.79
Instil Bio Inc Stock (TIL) Company Profile
Name
Instil Bio Inc
Sector
Industry
Phone
(972) 499-3350
Address
3963 MAPLE AVENUE, DALLAS
Compare TIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TIL
Instil Bio Inc
|
14.81 | 101.87M | 0 | -74.14M | -65.70M | -11.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.20 | 103.89B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
654.74 | 69.11B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.70 | 58.49B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
869.83 | 52.62B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
191.92 | 40.46B | 447.02M | -1.18B | -906.14M | -6.1812 |
Instil Bio Inc Stock (TIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-25 | Upgrade | Jefferies | Hold → Buy |
| Nov-04-24 | Initiated | JMP Securities | Mkt Perform |
| Apr-12-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Nov-01-22 | Downgrade | Truist | Buy → Hold |
| Aug-13-21 | Initiated | Robert W. Baird | Outperform |
| Apr-13-21 | Initiated | Cowen | Outperform |
| Apr-13-21 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-21 | Initiated | Truist | Buy |
View All
Instil Bio Inc Stock (TIL) Latest News
What hedge fund activity signals for Instil Bio Inc. stockRate Cut & Reliable Breakout Forecasts - newser.com
The Technical Signals Behind (TIL) That Institutions Follow - news.stocktradersdaily.com
Applying big data sentiment scoring on Instil Bio Inc.2025 EndofYear Setup & High Conviction Trade Alerts - newser.com
Will Instil Bio Inc. stock benefit from automationMarket Risk Analysis & Real-Time Stock Entry Alerts - newser.com
Is Instil Bio Inc. stock attractive for long term wealth buildingJuly 2025 Outlook & Real-Time Stock Price Movement Reports - newser.com
Signal strength of Instil Bio Inc. stock in tech scannersMarket Movement Recap & Safe Entry Momentum Tips - newser.com
Can Instil Bio Inc. stock maintain growth trajectoryJuly 2025 Volume & Low Drawdown Investment Ideas - newser.com
Will Instil Bio Inc. stock maintain momentum in 2025July 2025 Trends & Consistent Profit Trade Alerts - newser.com
Chart based exit strategy for Instil Bio Inc.July 2025 Catalysts & Safe Investment Capital Preservation Plans - newser.com
Published on: 2025-11-09 03:11:23 - newser.com
Heatmap analysis for Instil Bio Inc. and competitors2025 Breakouts & Breakdowns & Trade Opportunity Analysis Reports - newser.com
Instil Bio Inc expected to post a loss of $2.35 a shareEarnings Preview - TradingView
Applying Wyckoff theory to Instil Bio Inc. stockEarnings Overview Summary & Fast Exit and Entry Trade Guides - newser.com
Key metrics from Instil Bio Inc.’s quarterly dataLong Setup & Risk Controlled Swing Alerts - newser.com
How Instil Bio Inc. stock reacts to job market data2025 Price Momentum & Growth Oriented Trade Recommendations - newser.com
Why Instil Bio Inc. stock appeals to analystsWeekly Investment Recap & Reliable Breakout Forecasts - newser.com
Why Instil Bio Inc. stock remains on buy lists2025 Market Sentiment & Verified Technical Trade Signals - newser.com
Is Instil Bio Inc. showing signs of accumulationJuly 2025 Patterns & Risk Controlled Daily Plans - newser.com
Regression analysis insights on Instil Bio Inc. performanceEarnings Growth Summary & Fast Exit/Entry Strategy Plans - newser.com
Evaluating Instil Bio Inc. with trendline analysisWeekly Trade Recap & Verified Momentum Watchlists - newser.com
Will Instil Bio Inc. stock deliver better than expected guidance2025 Momentum Check & Weekly High Return Opportunities - fcp.pa.gov.br
What to expect from Instil Bio Inc. in the next 30 days2025 Short Interest & Daily Profit Focused Screening - newser.com
Instil Bio Inc Stock (TIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Instil Bio Inc Stock (TIL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Laumas Sandeep | CFO and CBO |
Sep 10 '25 |
Sale |
23.39 |
30,000 |
701,667 |
0 |
0.05%
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):